Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
55
Views
1
CrossRef citations to date
0
Altmetric
Original Research

AMPH-1 As A Critical Tumor Suppressor That Inhibits Osteosarcoma Progression

Haiyun Zhang1 Department of Laboratory Medicine, The Sixth People’s Hospital of Nantong, Jiangsu226000, People’s Republic of China
,
Yujie Liu2 Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, People’s Republic of China
,
Kehan Xu2 Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, People’s Republic of China
,
Kai Mao1 Department of Laboratory Medicine, The Sixth People’s Hospital of Nantong, Jiangsu226000, People’s Republic of China
,
Weidong Han1 Department of Laboratory Medicine, The Sixth People’s Hospital of Nantong, Jiangsu226000, People’s Republic of China
,
Feifan Xu1 Department of Laboratory Medicine, The Sixth People’s Hospital of Nantong, Jiangsu226000, People’s Republic of China
,
Wei Wan2 Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, 200003, People’s Republic of China
&
Yajun Sun3 Department of Laboratory Medicine, The Fourth People’s Hospital of Nantong, Jiangsu226000, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 9913-9919 | Published online: 25 Nov 2019

References

  • Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.20213383
  • Franke M, Hardes J, Helmke K, et al. Solitary skeletal osteosarcoma recurrence. Findings from the cooperative osteosarcoma study group. Pediatr Blood Cancer. 2011;56:771–776.21370409
  • de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M. The landscape of medical oncology in Europe by 2020. Ann Oncol. 2014;25:525–528. doi:10.1093/annonc/mdt55924425791
  • Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol. 2005;58:96–107. doi:10.1002/ana.v58:115984030
  • Wigge P, Kohler K, Vallis Y, et al. Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell. 1997;8:2003–2015. doi:10.1091/mbc.8.10.20039348539
  • De Jesus-Cortes HJ, Nogueras-Ortiz CJ, Gearing M, Arnold SE, Vega IE. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration. Neuroreport. 2012;23:942–946. doi:10.1097/WNR.0b013e32835982ce22975846
  • Sekiguchi M, Katayama S, Hatano N, Shigeri Y, Sueyoshi N, Kameshita I. Identification of amphiphysin 1 as an endogenous substrate for CDKL5, a protein kinase associated with X-linked neurodevelopmental disorder. Arch Biochem Biophys. 2013;535:257–267. doi:10.1016/j.abb.2013.04.01223651931
  • Wu Y, Matsui H, Tomizawa K. Amphiphysin I and regulation of synaptic vesicle endocytosis. Acta Med Okayama. 2009;63:305–323. doi:10.18926/AMO/3182220035287
  • Takei K, Slepnev VI, Haucke V, De Camilli P. Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis. Nat Cell Biol. 1999;1:33–39. doi:10.1038/900410559861
  • Decamilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med. 1993;178:2219–2223. doi:10.1084/jem.178.6.22198245793
  • David C, McPherson PS, Mundigl O, de Camilli P. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals. Proc Natl Acad Sci U S A. 1996;93:331–335. doi:10.1073/pnas.93.1.3318552632
  • Folli F, Solimena M, Cofiell R, et al. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N Engl J Med. 1993;328:546–551. doi:10.1056/NEJM1993022532808058381208
  • Mundigl O, Ochoa GC, David C, Slepnev VI, Kabanov A, De Camilli P. Amphiphysin I antisense oligonucleotides inhibit neurite outgrowth in cultured hippocampal neurons. J Neurosci. 1998;18:93–103. doi:10.1523/JNEUROSCI.18-01-00093.19989412489
  • Yoo J, Jeong MJ, Kwon BM, Hur MW, Park YM, Han MY. Activation of dynamin I gene expression by Sp1 and Sp3 is required for neuronal differentiation of N1E-115 cells. J Biol Chem. 2002;277:11904–11909. doi:10.1074/jbc.M11178820011809758
  • Yang H, Wan Z, Huang C, Yin H, Song D. AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway. Lasers Med Sci. 2019;34:473–478. doi:10.1007/s10103-018-2616-430143925
  • Crouzet M, Urdaci M, Dulau L, Aigle M. Yeast mutant affected for viability upon nutrient starvation: characterization and cloning of the RVS161 gene. Yeast. 1991;7:727–743. doi:10.1002/(ISSN)1097-00611776363
  • Floyd S, Butler MH, Cremona O, et al. Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer. Mol Med. 1998;4:29–39. doi:10.1007/BF034017279513187
  • Dropcho EJ. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis. Ann Neurol. 1996;39:659–667. doi:10.1002/(ISSN)1531-82498619552
  • Otsuka A, Hirose K, Kilimann MW, Kamata T. Amphiphysin1 inhibits vitronectin-mediated cell adhesion, spreading, and migration in vitro. Biochem Biophys Res Commun. 2003;301:769–775. doi:10.1016/S0006-291X(03)00040-812565847
  • Faghfuri E, Nikfar S, Niaz K, Faramarzi MA, Abdollahi M. Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors. Expert Opin Drug Metab Toxicol. 2018;14:317–330. doi:10.1080/17425255.2018.143259329363351

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.